[1] PR/SET Domain Family and Cancer: Novel Insights from The Cancer Genome Atlas

[2] Navigating thyroid cancer: a theranostics odyssey "joining the dots to make a line"

[3] Treatment duration with immune-based therapies in Cancer: an enigma

[4] Immunotherapy in the Treatment of Biliary Tract Cancer: The Future?

[5] Correction to: Treatment duration with immune-based therapies in Cancer: an enigma

[6] Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

[7] The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

[8] Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

[9] Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.

[10] Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.

[11] Risk Factors of Cervical Cancer: A Case-Control Study.

[12] Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: An in vivo study.

[13] Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief

[14] FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.

[15] The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review

[16] Use of vitamin K antagonists and risk of prostate cancer: Meta–analysis and nationwide case–control study

[17] EGFR signaling in colorectal cancer: a clinical perspective

[18] A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

[19] EGFR signaling in colorectal cancer: a clinical perspective

[20] EGFR signaling in colorectal cancer: a clinical perspective

[21] A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

[22] Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death

[23] Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research.

[24] Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).

[25] Genetics of breast cancer: Applications to the Mexican population

[26] Parents of children diagnosed with cancer: work situation and sick leave, a five-year post end-of-treatment or a child's death follow-up study.

[27] Gaining consent to freeze spermatozoa from adolescents with cancer: legal, ethical and practical aspects.

[28] Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluation.

[29] Resilience in middle-aged partners of patients diagnosed with incurable cancer: A thematic analysis.

[30] Clinical decision support for therapeutic decision-making in cancer: A systematic review.

[31] E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.

[32] The measurement scale of resilience among family caregivers of children with cancer: a psychometric evaluation.

[33] Value of intra-operative Doppler sonographic measurements in predicting post-operative anastomotic leakage in rectal cancer: a prospective pilot study.

[34] Traveling With Cancer: A Guide for Oncologists in the Modern World.

[35] Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.

[36] Molecular Inverse Comorbidity between Alzheimer's Disease and Lung Cancer: New Insights from Matrix Factorization.

[37] Metabolomics workflow for lung cancer: Discovery of biomarkers.

[38] Risk Estimation, Anxiety and Breast Cancer Worry in Women at Risk for Breast Cancer: A Single-Arm Trial of Personalized Risk Communication.

[39] Predicting Overall Survival in Patients with Metastatic Rectal Cancer: a Machine Learning Approach.

[40] Association between Cryptosporidium infection and cancer: A systematic review and meta-analysis.

[41] United against cancer: prevention to end-of-life care-highlights from the Uganda Cancer Institute-Palliative Care Association of Uganda Joint International Conference on Cancer and Palliative Care and the 7th Palliative Care Conference, 24-25 August 2017, Kampala, Uganda.

[42] Primary hepatocellular carcinoma in a patient with history of treated breast cancer: a case report with challenging diagnosis and treatment

[43] The incidence proportion of erectile dysfunction in patients treated with cryotherapy for prostate cancer: a meta-analysis

[44] Effect of Vitamin D Supplementation in Prostate Cancer: A Systematic Review of Randomized Control Trials.

[45] Prostate cancer: Calcium promotes cancer; vitamin D decelerates.

[46] Vertigo in patients with cancer: Red flag symptoms.

[47] Treatment of Skin Reaction Induced by Nivolumab Combined with Radiotherapy in Non-small Cell Lung Cancer: A Case Report.

[48] PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue

[49] Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.

[50] Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

[51] Photodynamic therapy for prostate cancer: a systematic review and meta-analysis.

[52] Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

[53] Prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

[54] Prostate cancer: Open vs laparoscopic vs robotic RP - The biggest study to date

[55] Screening mammography beyond breast cancer: breast arterial calcifications as a sex-specific biomarker of cardiovascular risk.

[56] Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis.

[57] The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol

[58] Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application

[59] Mediterranean diet adherence and risk of colorectal cancer: the prospective Netherlands Cohort Study.

[60] Surgical Outcomes and Prognostic Factors in Cervical Cancer: A 12 year, Single-Center Experience

[61] Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features.

[62] Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

[63] Detection at Public Facilities of I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients.

[64] Effects of laughter therapy on quality of life in patients with cancer: An open-label, randomized controlled trial.

[65] The energy-enhancing potential of participatory performance-based arts activities in the care of people with a diagnosis of cancer: an integrative review.

[66] Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies.

[67] [Orthotopic neobladder reconstruction for bladder cancer: robotic-assisted versus open-radical cystectomy for perioperative outcomes, functional results and quality of life].

[68] Diseases of renal function and bone metabolism following treatment for early-onset cancer: A registry-based study.

[69] The PI3K/AKT/mTOR and CDK4/6 pathways in endocrine resistant HR+/HER2- metastatic breast cancer: Biological mechanisms and new treatments

[70] Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.

[71] Demographic characteristics, nutritional behaviors, and orthorexic tendencies of women with breast cancer: a case-control study.

[72] Supportive care needs of patients following treatment for colorectal cancer: risk factors for unmet needs and the association between unmet needs and health-related quality of life-results from the ColoREctal Wellbeing (CREW) study.

[73] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Guidelines.

[74] Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

[75] Social support in cancer: How do patients want us to help?

[76] Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.

[77] Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.

[78] Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials.

[79] Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

[80] Patient Navigation in Cancer: The Business Case to Support Clinical Needs.

[81] Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel.

[82] Adjuvant Chemotherapy in Colorectal Cancer: Mournful, Hopeful Perpetual Motion Machine Heads to Dim Light at End of Tunnel

[83] Anti-Tumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation.

[84] Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.

[85] Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial

[86] The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

[87] Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study.

[88] Development of Exercise as Interception Therapy for Cancer: A Review.

[89] Zenker’s diverticulum and squamous esophageal cancer: a case report

[90] Exacerbation of Dermatomyositis with Recurrence of Rectal Cancer: A Case Report

[91] Problems sleeping with prostate cancer: exploring possible risk factors for sleep disturbance in a population-based sample of survivors.

[92] Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population.

[93] Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

[94] Mouse Models of Thyroid Cancer: Bridging Pathogenesis and Novel Therapeutics.

[95] Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy

[96] Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.

[97] Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

[98] Cosmetic assessment in brachytherapy (interventional radiotherapy) for breast cancer: A multidisciplinary review.

[99] Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).

[100] Early diagnosis in gastric cancer: Pilot project

[101] Feature engineering applied to intraoperative in vivo Raman spectroscopy sheds light on molecular processes in brain cancer: a retrospective study of 65 patients.